The role of salivary caffeine clearance in the diagnosis of chronic liver disease

Journal of Oral Biology and Craniofacial Research

Volumn 5, Issue 1, 2015, Pages 28-33

  Tripathi, Anurag ^a   Tiwari, Brijesh ^b   Patil, Ranjit ^a   Khanna, Vikram ^a   Singh, Vandana ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Caffeine 1, 3, 7 tri methyl xanthine; Child pugh classification; EMIT; Liver cirrhosis

Indexed keywords

EID: 84969168101     PISSN: 22124268     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jobcr.2014.12.003     Document Type: Article

References (24)

1. McDonagh J.E. Caffeine clearance by enzyme multiplied immunoassay technique: a simple, inexpensive, and useful indicator of liver function. Gut 1991, 32:681-684.
2. Limdi J.K., Hyde G.M. Evaluation of abnormal liver function tests. Postgrad Med J 2003, 79:307-312.
3. Daniel S.P., Marshall M.K. Evaluation of the Liver: Laboratory Tests. Schiff's Diseases of the Liver 1999, 205-239. JB Lippincott publications, USA. 8th ed.
4. Sherlock S. Assessment of Liver Function Disease of Liver and Biliary System: Sheila Sherlock 1997, 17-32. Blackwell science ltd, London. 10th ed.
5. Tarantino Giovanni Could quantitative liver function tests gain wide acceptance among hepatologists?. World J Gastroenterol: WJG 2009, 15:3457-3461.
6. Friedman L.S., Martin P., Munoz S.J. Liver function tests and the objective evaluation of the patient with liver disease. Hepatology: A Textbook of Liver Disease 1996, 791-833. WB Saunders, Philadelphia. 3rd ed. D. Zakin, T.D. Boyer (Eds.).
7. Leevy C.M., Mendenhall C.L., Lesko W., Howard M.M. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962, 41:1169-1179.
8. Merkel C., Gatta A., Zoli M., et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991, 36:1197-1203.
9. Bircher J., Kupfer A., Gikalov I., Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther 1976, 20:484-492.
10. Wasserman K., Zhang Y.Y., Gitt A., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997, 96:2221-2227.
11. Jost G., Wahllander A., Mandach U., Preisig R. Overnight salivary caffeine clearance: a liver function test suitable for routine use. Hepatology 1987, 7:338-344.
12. Blancharad J., Sawers S.J.A. The absolute bioavailability of caffeine in man. Eur J Clin Pharmacol 1983, 24:93-98.
13. Arnaud M.J., Welsch C. Caffeine metabolism in human subjects. IXth International Colloquium on the Science and Technology of Coffee 1981, 385-396. Association Scientifiques Intemationale du Cafd, London.
14. Baker A., Girling A., Worthington D., et al. The prognostic significance of caffeine half-life in saliva in children with chronic liver disease. J Pediatr Gastroenterol Nutr 1995 Feb, 20:196-201.
15. Scott N.R., Stambuk D., Chakraborty J., Marks V., Morgan M.Y. The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease. Br J Clin Pharmac 1989, 27:205-213.
16. Jover R., Carnicer F., Sánchez-Payá J., Climent E., Sirvent M., Marco J.E.L. Salivary caffeine clearance predicts survival in patients with liver cirrhosis. Am J Gastroenterology 1997, 92:1905-1908.
17. François, Valla Dominique Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatology 2005, 42:S100-S107.
18. Zysset T., Wahlländer A., Preisig R. Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method. Ther Drug Monit 1984, 6:348-354.
19. Bonati M., Latini R., Galletti F., Young J.F., Tognoni G., Garattini S. Caffeine disposition after oral doses. Clin Pharmacol Ther 1982, 32:98-106.
20. Wahlländer A., Mohr S., Paumgartner G. Assessment of hepatic function. Comparison of caffeine clearance in serum and saliva during the day and at night. J Hepatol 1990, 10:129-137.
21. Biederbick W., Joseph G., Rump A., Theisohn M., Klaus W. Caffeine in saliva after peroral intake: early sample collection as a possible source of error. Ther Drug Monit 1997, 19:521-524.
22. Marchesini G., Checchia G.A., Grossi G., et al. Caffeine intake, fasting plasma caffeine and caffeine clearance in patients with liver diseases. Liver Int 09/1988, 8:241-246.
23. Lewis F.W., Rector W.G. Caffeine clearance in cirrhosis: the value of simplified determinations of liver metabolic capacity. J Hepatology 1992, 14:157-162.
24. Holstege A., Staiger M., Haag K., Gerok W. Correlation of caffeine elimination and Child's classification in liver cirrhosis. Klin Wochenschr 1989, 67:6-15.